Jan 17, 2019 Immune Pharmaceuticals Inc. Up to 123,333,333 Shares of common stock. This prospectus relates to the resale or other disposition by the

Immune Pharmaceuticals Inc. Up to 123,333,333 Shares of common stock . Our common stock may be subject to the “penny stock” rules of the SEC,

As a result of the reverse stock split, the number of shares of Immune's common stock outstanding will decrease from approximately 194.3 million shares pre-split to approximately 9.7 million 2017-04-12 · NEW YORK, April 12, 2017 / PRNewswire / -- Immune Pharmaceuticals Inc. (Nasdaq: IMNP) ("Immune" or the "Company"), today announced a reverse stock split of its shares of common stock at a ratio of 1-for-20. Beginning with the opening of trading on April 13, 2017, the Company's common stock will continue to trade The Nasdaq Capital Market ("Nasdaq") 2019-11-06 sec.gov - PROSPECTUS SUPPLEMENT NO. 8 (TO PROSPECTUS DATED APRIL 25, 2014) Filed pursuant to Rule 424(b)(3) under the Securities Act of 1933 in connection with Registration Statement No. 333-195251 Immune Pharmaceuticals Inc. 7,293,242 Shares of Common Stock This prospectus supplement No. 8 supplements and amends the prospectus dated April 25, 2014, as supplemented and amended by prospectus supplement No.1, 2019-11-08 sec.gov - Filed Pursuant to Rule 424(b)(2) Registration No. 333-198647 PROSPECTUS IMMUNE PHARMACEUTICALS INC. $75,000,000 COMMON STOCK PREFERRED STOCK DEBT SECURITIES WARRANTS RIGHTS PURCHASE CONTRACTS UNITS This prospectus will allow us to issue, from time to time at prices and on terms to be determined at or prior to the time of the offering, up to $75,000,000 of any combination Immune Pharmaceuticals, Inc. - IMNPQ Stock Chart Technical Analysis for 04-13-2021Subscribe to My MAIN Channel Here: https://www.youtube.com/claytrader/Free Immune Pharmaceuticals (PK) (IMNPQ) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Immune Pharmaceuticals Inc – COMMON STOCK PURCHASE AGREEMENT (February 3rd, 2017)COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of February 3, 2017 by and between IMMUNE PHARMACEUTICALS INC., a Delaware corporation (the “Company”), and HLHW IV, LLC, a Delaware limited liability company (the “Buyer”).

Immune pharmaceuticals inc common stock

4,019.87. NASDAQ. 13,480.11. FTSE 100. 6,737.30. 2021-04-13 A high-level overview of Immune Pharmaceuticals Inc. (IMNPQ) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Immune Pharmaceuticals common stock dividends paid from 2006 to 2018. Common stock dividends paid can be defined as the cash outflow for dividends paid on a company's common stock

Avnoterad från First North den 9 mars, senast betalt denna dag var 3,26 kr. 2013. Ny notering på First North 2 december. Överförd från Nordiska listan.

Immune Pharmaceuticals Inc., is a clinical-stage biopharmaceutical company. It is engaged in the development of novel targeted therapeutic agents in the fields of immunology, inflammation, dermatology and oncology. It operates though acquiring, developing and …

0.14 / 0.142 Immune Pharmaceuticals Inc. 7,500 Units consisting of Series E convertible preferred stock and warrants (and shares of common stock underlying shares of Immune Pharmaceuticals Inc. (Exact name of registrant as specified in its charter) . Delaware, 52-1841431. (State or other jurisdiction of incorporation or This page shows recent SEC filings related to Immune Pharmaceuticals Inc. between Immune Pharmaceuticals Inc., a Delaware corporation (“Company”) and Records 1 - 18 of 20 Related Symbols. GME. GameStop Corporation Common Stock. $181.00 -2.75 1.5%. Apr 9, 2021 Find the latest news headlines from Immune Pharmaceuticals Inc (IMNPQ) at AMC Entertainment Holdings, Inc. Class A Common Stock. Oct 19, 2017 Immune Pharmaceuticals Inc. (“Immune”) (NASDAQ: IMNP) a Stock is convertible into shares of common stock by dividing the stated value of Real-time trade and investing ideas on Immune Pharmaceuticals IMNPQ from the "Q" *ALL COMMON SHARES stay in tact $$$ ULTRA BULLISH$$$ $RGBP Find the latest IMMUNE PHARMACEUTICALS INC (IMNPQ) stock quote, history, news and other vital information to help you with your stock trading and OTC Stock performance charts for Immune Pharmaceuticals.

41.41%. 0.14 / 0.142 Immune Pharmaceuticals Inc. 7,500 Units consisting of Series E convertible preferred stock and warrants (and shares of common stock underlying shares of Immune Pharmaceuticals Inc. (Exact name of registrant as specified in its charter) . Delaware, 52-1841431.
Korsord aftonbladet hjälp

Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid Immune Pharmaceuticals Inc – COMMON STOCK PURCHASE AGREEMENT (February 3rd, 2017)COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of February 3, 2017 by and between IMMUNE PHARMACEUTICALS INC., a Delaware corporation (the “Company”), and HLHW IV, LLC, a Delaware limited liability company (the “Buyer”).

The Company provides novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Immune Immune Pharmaceuticals, Inc. operates as a biopharmaceutical company.
Teater brunkebergstorg

A high-level overview of Immune Pharmaceuticals Inc. (IMNPQ) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Get the latest IMMUNE PHARMACEUTICALS INC (IMNPQ) stock news and headlines to help you in your trading and investing decisions. Company profile page for Immune Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information 2019-11-08 sec.gov - Filed Pursuant to Rule 424(b)(2) Registration No. 333-198647 PROSPECTUS IMMUNE PHARMACEUTICALS INC. $75,000,000 COMMON STOCK PREFERRED STOCK DEBT SECURITIES WARRANTS RIGHTS PURCHASE CONTRACTS UNITS This prospectus will allow us to issue, from time to time at prices and on terms to be determined at or prior to the time of the offering, up to … Immune Pharmaceuticals Inc., is a clinical-stage biopharmaceutical company. It is engaged in the development of novel targeted therapeutic agents in the fields of immunology, inflammation, dermatology and oncology. It operates though acquiring, developing and … 2021-03-23 Company Name: Immune Pharmaceuticals Inc., Stock Symbol: IMNPQ, Industry: Biotechs, Total Posts: 9918, Last Post: 4/12/2021 3:19:03 PM Support: 888-992-3836 | NewsWire | … As a result of the reverse stock split, the number of shares of Immune's common stock outstanding will decrease from approximately 194.3 million shares pre-split to approximately 9.7 million 2017-04-12 Kommentarer.

Company Name: Immune Pharmaceuticals Inc., Stock Symbol: IMNPQ, Industry: Biotechs, Total Posts: 9918, Last Post: 4/12/2021 3:19:03 PM

IMNPQ | Complete Immune Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Immune Pharmaceuticals Inc. Announces Pricing of $18,000,000 Public Offering of Convertible Preferred Stock and Warrants October 19, 2017 09:00 AM Eastern Daylight Time 2014-11-25 · Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants Immune has raised total gross proceeds of $9.625 million in November 2014 Nov 25, 2014 Company Name: Immune Pharmaceuticals Inc., Stock Symbol: IMNPQ, Industry: Biotechs, Total Posts: 10108, Last Post: 4/15/2021 5:09:39 PM. Immune Pharmaceuticals Inc. Common Stock. 0.14. 0.041. 41.41%. 0.14 / 0.142 Immune Pharmaceuticals Inc. 7,500 Units consisting of Series E convertible preferred stock and warrants (and shares of common stock underlying shares of Immune Pharmaceuticals Inc. (Exact name of registrant as specified in its charter) . Delaware, 52-1841431.